Caplin Point Laboratories Limited (CAPLIPOINT) — Financial Results
Caplin Point Laboratories Limited announced closure of its trading window effective April 1, 2026, in accordance with SEBI insider trading regulations. The closure is tied to finalization of audited financial statements for the fiscal year ending March 31, 2026. The trading window will reopen 48 hours after financial results are declared to stock exchanges.
About Caplin Point Laboratories Limited (CAPLIPOINT)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when CAPLIPOINT files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track CAPLIPOINT — Free💡 Ask AI about this filing
📊 More CAPLIPOINT filings
- Announcement — 11 July 2026 Caplin Point Laboratories announced receipt of a SEBI-mandated confirmation certificate from its reg...
- Financial Results — 27 June 2026 Caplin Point Laboratories announced that its trading window will close on July 1, 2026, to facilitat...
- regulation 31 — 16 June 2026 Caplin Point Laboratories disclosed on April 6, 2026, that no encumbrance on its shares was created ...
- Announcement — 14 May 2026 Caplin Point Laboratories announced that its subsidiary Caplin Steriles received final USFDA approva...
- 🔴 Corporate Action — 14 May 2026 Caplin Point Laboratories announced an interim dividend of INR 4 per share (200% payout) for FY26, w...
🔥 Also filed on 27 March 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when CAPLIPOINT files new disclosures
Track CAPLIPOINT filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CAPLIPOINT — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research